Maker of Wegovy, Ozempic Showers Money on U.S. Obesity Doctors
Reuters

Drugmaker Novo Nordisk paid at least $25.8 million to an elite group of U.S. obesity specialists who advocate giving its expensive weight-loss drugs to millions of Americans. Payments also go to persuade skeptical insurers to pay for it.
Spread the word